Psoriatic Arthritis
Conference Coverage
Serious infections are increasing among psoriasis inpatients
Key clinical point: Psoriasis is an independent risk factor for serious infections, and serious infections are increasing among inpatients with...
Conference Coverage
PIANO study provides insight on safety of biologics in pregnancy
News
Brodalumab effective for rare, severe types of psoriasis
Key clinical point: The interluekin-17 inhibitor brodalumab significantly improved symptoms of generalized pustular psoriasis and psoriatic...
Conference Coverage
Remicade to infliximab biosimilar switches fare well in real-life practice
Key clinical point: Both biosimilar versions of infliximab available in Europe appear to be as effective and tolerated as Remicade after switching...
Conference Coverage
Effective psoriasis therapy may reduce coronary plaque burden
Key clinical point: Improved PASI scores were linked to regression of early noncalcified coronary plaque. Major finding: Reduction in skin...
News
After Inflectra’s approval, challenges remain for biosimilars
Now that the FDA has approved Inflectra as the first biosimilar version of Remicade, rheumatologists and patient advocacy groups are taking stock...
News
Psoriasis tied to abdominal aortic aneurysm in nationwide study
Key clinical point: Psoriasis predicted abdominal aortic aneurysm in a large, population-based study. Major finding: The adjusted risk of...
News
Clazakizumab safe, effective for PsA treatment
News
Inflectra becomes first FDA-approved biosimilar for inflammatory diseases
Conference Coverage
Severe psoriasis, kidney disease linked
Key clinical point: Severe psoriasis appears to increase the risk of both immunoglobulin A glomerulonephritis and glomerular disease. Major...